TY - JOUR
T1 - Nucleosides-126. Selective methylation of the C-nucleoside, ψ-isocytidine and its 2 $ ́-deoxy analog. Synthesis of 1-methyl, 3-methyl and 4-o-methyl derivatives
AU - Pankiewicz, K. W.
AU - Matsuda, A.
AU - Watanabe, K. A.
AU - Fox, J. J.
N1 - Funding Information:
This inv~~i~tion-wes upportedi,n par?,b y funds from the NationalC ancerI nstitute.D .H.H.S.. Grants CA-08748 and CA-18601.
PY - 1984
Y1 - 1984
N2 - Methods were developed to prepare 1 -methyl-, 3-methyl- and 4-0-methyl-ψ-isocytidine by selective methylation.3, ́5 - ́O-Tetraisopropyldisiloxanyl-ψ isocytidine (8) was trimethylsilylated and then treated with MeI and, after deprotection, 1 -methyl-ψ isocytidine (6) was obtained. The 2 - ́deoxy analog (7) was also prepared in a similar manner from the 2 - ́deoxy analog (10) of 8. Treatment of 8 with CH2N2 afforded the 3-methyl-ψ-isocytidine derivative (19) as the major product. Methylation with diazomethane also occurred mainly on N3 of the 2 - ́deoxy analog 10 to form 20. Removal of the 3, ́ 5 - ́O-protecting group from 19 and 20 afforded 3-methyl-ψ-isocytidine (14) and its 2-deoxy analog (15), respectively. 2-N-Acetyl- 3, ́5 - ́O-tetraisopropyldisiloxanyl-ψ-isocytidine (24), on the other hand, gave the 4-O-methyl derivative (25) as the major product upon CH2N2 treatment. Subsequent deprotection of 25 afforded 4-O-methyl-ψ-isocytidine (29). aiv51b1p33b.
AB - Methods were developed to prepare 1 -methyl-, 3-methyl- and 4-0-methyl-ψ-isocytidine by selective methylation.3, ́5 - ́O-Tetraisopropyldisiloxanyl-ψ isocytidine (8) was trimethylsilylated and then treated with MeI and, after deprotection, 1 -methyl-ψ isocytidine (6) was obtained. The 2 - ́deoxy analog (7) was also prepared in a similar manner from the 2 - ́deoxy analog (10) of 8. Treatment of 8 with CH2N2 afforded the 3-methyl-ψ-isocytidine derivative (19) as the major product. Methylation with diazomethane also occurred mainly on N3 of the 2 - ́deoxy analog 10 to form 20. Removal of the 3, ́ 5 - ́O-protecting group from 19 and 20 afforded 3-methyl-ψ-isocytidine (14) and its 2-deoxy analog (15), respectively. 2-N-Acetyl- 3, ́5 - ́O-tetraisopropyldisiloxanyl-ψ-isocytidine (24), on the other hand, gave the 4-O-methyl derivative (25) as the major product upon CH2N2 treatment. Subsequent deprotection of 25 afforded 4-O-methyl-ψ-isocytidine (29). aiv51b1p33b.
UR - http://www.scopus.com/inward/record.url?scp=48749138511&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=48749138511&partnerID=8YFLogxK
U2 - 10.1016/0040-4020(84)85100-5
DO - 10.1016/0040-4020(84)85100-5
M3 - Article
AN - SCOPUS:48749138511
SN - 0040-4020
VL - 40
SP - 33
EP - 38
JO - Tetrahedron
JF - Tetrahedron
IS - 1
ER -